Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes

Autores
Mucci, Juan Sebastián; Carmona, Santiago Javier; Volcovich, Romina; Altcheh, Jaime Marcelo; Bracamonte, María Estefanía; Marco, Jorge Diego; Nielsen, Morten; Buscaglia, Carlos Andres; Agüero, Fernan Gonzalo
Año de publicación
2017
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Chagas Disease, caused by the protozoan Trypanosoma cruzi, is a major health and economicproblem in Latin America for which no vaccine or appropriate drugs for large-scalepublic health interventions are yet available. Accurate diagnosis is essential for the earlyidentification and follow up of vector-borne cases and to prevent transmission of the diseaseby way of blood transfusions and organ transplantation. Diagnosis is routinely performedusing serological methods, some of which require the production of parasite lysates, parasiteantigenic fractions or purified recombinant antigens. Although available serologicaltests give satisfactory results, the production of reliable reagents remains laborious andexpensive. Short peptides spanning linear B-cell epitopes have proven ideal serodiagnosticreagents in a wide range of diseases. Recently, we have conducted a large-scale screeningof T. cruzi linear B-cell epitopes using high-density peptide chips, leading to the identificationof several hundred novel sequence signatures associated to chronic Chagas Disease.Here, we performed a serological assessment of 27 selected epitopes and of their use in anovel multipeptide-based diagnostic method. A combination of 7 of these peptides werefinally evaluated in ELISA format against a panel of 199 sera samples (Chagas-positive andnegative, including sera from Leishmaniasis-positive subjects). The multipeptide formulationdisplayed a high diagnostic performance, with a sensitivity of 96.3% and a specificity of99.15%. Therefore, the use of synthetic peptides as diagnostic tools are an attractive alternativein Chagas´ disease diagnosis.
Fil: Mucci, Juan Sebastián. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; Argentina
Fil: Carmona, Santiago Javier. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; Argentina
Fil: Volcovich, Romina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentina
Fil: Altcheh, Jaime Marcelo. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentina
Fil: Bracamonte, María Estefanía. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; Argentina
Fil: Marco, Jorge Diego. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; Argentina
Fil: Nielsen, Morten. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; Argentina
Fil: Buscaglia, Carlos Andres. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; Argentina
Fil: Agüero, Fernan Gonzalo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; Argentina
Materia
Trypanosoma cruzi
serodiagnosis
peptide
antigen
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/48673

id CONICETDig_92186c6bcf6b2b50fba7a305db99c513
oai_identifier_str oai:ri.conicet.gov.ar:11336/48673
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopesMucci, Juan SebastiánCarmona, Santiago JavierVolcovich, RominaAltcheh, Jaime MarceloBracamonte, María EstefaníaMarco, Jorge DiegoNielsen, MortenBuscaglia, Carlos AndresAgüero, Fernan GonzaloTrypanosoma cruziserodiagnosispeptideantigenhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Chagas Disease, caused by the protozoan Trypanosoma cruzi, is a major health and economicproblem in Latin America for which no vaccine or appropriate drugs for large-scalepublic health interventions are yet available. Accurate diagnosis is essential for the earlyidentification and follow up of vector-borne cases and to prevent transmission of the diseaseby way of blood transfusions and organ transplantation. Diagnosis is routinely performedusing serological methods, some of which require the production of parasite lysates, parasiteantigenic fractions or purified recombinant antigens. Although available serologicaltests give satisfactory results, the production of reliable reagents remains laborious andexpensive. Short peptides spanning linear B-cell epitopes have proven ideal serodiagnosticreagents in a wide range of diseases. Recently, we have conducted a large-scale screeningof T. cruzi linear B-cell epitopes using high-density peptide chips, leading to the identificationof several hundred novel sequence signatures associated to chronic Chagas Disease.Here, we performed a serological assessment of 27 selected epitopes and of their use in anovel multipeptide-based diagnostic method. A combination of 7 of these peptides werefinally evaluated in ELISA format against a panel of 199 sera samples (Chagas-positive andnegative, including sera from Leishmaniasis-positive subjects). The multipeptide formulationdisplayed a high diagnostic performance, with a sensitivity of 96.3% and a specificity of99.15%. Therefore, the use of synthetic peptides as diagnostic tools are an attractive alternativein Chagas´ disease diagnosis.Fil: Mucci, Juan Sebastián. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; ArgentinaFil: Carmona, Santiago Javier. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; ArgentinaFil: Volcovich, Romina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; ArgentinaFil: Altcheh, Jaime Marcelo. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; ArgentinaFil: Bracamonte, María Estefanía. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; ArgentinaFil: Marco, Jorge Diego. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; ArgentinaFil: Nielsen, Morten. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; ArgentinaFil: Buscaglia, Carlos Andres. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; ArgentinaFil: Agüero, Fernan Gonzalo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; ArgentinaPublic Library of Science2017-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/48673Mucci, Juan Sebastián; Carmona, Santiago Javier; Volcovich, Romina; Altcheh, Jaime Marcelo; Bracamonte, María Estefanía; et al.; Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes; Public Library of Science; Neglected Tropical Diseases; 11; 10; 10-2017; 1-191935-2735CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://dx.plos.org/10.1371/journal.pntd.0005972info:eu-repo/semantics/altIdentifier/url/http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0005972info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:58:13Zoai:ri.conicet.gov.ar:11336/48673instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:58:14.228CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes
title Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes
spellingShingle Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes
Mucci, Juan Sebastián
Trypanosoma cruzi
serodiagnosis
peptide
antigen
title_short Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes
title_full Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes
title_fullStr Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes
title_full_unstemmed Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes
title_sort Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes
dc.creator.none.fl_str_mv Mucci, Juan Sebastián
Carmona, Santiago Javier
Volcovich, Romina
Altcheh, Jaime Marcelo
Bracamonte, María Estefanía
Marco, Jorge Diego
Nielsen, Morten
Buscaglia, Carlos Andres
Agüero, Fernan Gonzalo
author Mucci, Juan Sebastián
author_facet Mucci, Juan Sebastián
Carmona, Santiago Javier
Volcovich, Romina
Altcheh, Jaime Marcelo
Bracamonte, María Estefanía
Marco, Jorge Diego
Nielsen, Morten
Buscaglia, Carlos Andres
Agüero, Fernan Gonzalo
author_role author
author2 Carmona, Santiago Javier
Volcovich, Romina
Altcheh, Jaime Marcelo
Bracamonte, María Estefanía
Marco, Jorge Diego
Nielsen, Morten
Buscaglia, Carlos Andres
Agüero, Fernan Gonzalo
author2_role author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Trypanosoma cruzi
serodiagnosis
peptide
antigen
topic Trypanosoma cruzi
serodiagnosis
peptide
antigen
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Chagas Disease, caused by the protozoan Trypanosoma cruzi, is a major health and economicproblem in Latin America for which no vaccine or appropriate drugs for large-scalepublic health interventions are yet available. Accurate diagnosis is essential for the earlyidentification and follow up of vector-borne cases and to prevent transmission of the diseaseby way of blood transfusions and organ transplantation. Diagnosis is routinely performedusing serological methods, some of which require the production of parasite lysates, parasiteantigenic fractions or purified recombinant antigens. Although available serologicaltests give satisfactory results, the production of reliable reagents remains laborious andexpensive. Short peptides spanning linear B-cell epitopes have proven ideal serodiagnosticreagents in a wide range of diseases. Recently, we have conducted a large-scale screeningof T. cruzi linear B-cell epitopes using high-density peptide chips, leading to the identificationof several hundred novel sequence signatures associated to chronic Chagas Disease.Here, we performed a serological assessment of 27 selected epitopes and of their use in anovel multipeptide-based diagnostic method. A combination of 7 of these peptides werefinally evaluated in ELISA format against a panel of 199 sera samples (Chagas-positive andnegative, including sera from Leishmaniasis-positive subjects). The multipeptide formulationdisplayed a high diagnostic performance, with a sensitivity of 96.3% and a specificity of99.15%. Therefore, the use of synthetic peptides as diagnostic tools are an attractive alternativein Chagas´ disease diagnosis.
Fil: Mucci, Juan Sebastián. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; Argentina
Fil: Carmona, Santiago Javier. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; Argentina
Fil: Volcovich, Romina. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentina
Fil: Altcheh, Jaime Marcelo. Gobierno de la Ciudad de Buenos Aires. Hospital General de Niños "Ricardo Gutiérrez"; Argentina
Fil: Bracamonte, María Estefanía. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; Argentina
Fil: Marco, Jorge Diego. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Salta. Instituto de Patología Experimental. Universidad Nacional de Salta. Facultad de Ciencias de la Salud. Instituto de Patología Experimental; Argentina
Fil: Nielsen, Morten. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; Argentina
Fil: Buscaglia, Carlos Andres. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; Argentina
Fil: Agüero, Fernan Gonzalo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata. Instituto de Investigaciones Biotecnológicas. Universidad Nacional de San Martín. Instituto de Investigaciones Biotecnológicas; Argentina
description Chagas Disease, caused by the protozoan Trypanosoma cruzi, is a major health and economicproblem in Latin America for which no vaccine or appropriate drugs for large-scalepublic health interventions are yet available. Accurate diagnosis is essential for the earlyidentification and follow up of vector-borne cases and to prevent transmission of the diseaseby way of blood transfusions and organ transplantation. Diagnosis is routinely performedusing serological methods, some of which require the production of parasite lysates, parasiteantigenic fractions or purified recombinant antigens. Although available serologicaltests give satisfactory results, the production of reliable reagents remains laborious andexpensive. Short peptides spanning linear B-cell epitopes have proven ideal serodiagnosticreagents in a wide range of diseases. Recently, we have conducted a large-scale screeningof T. cruzi linear B-cell epitopes using high-density peptide chips, leading to the identificationof several hundred novel sequence signatures associated to chronic Chagas Disease.Here, we performed a serological assessment of 27 selected epitopes and of their use in anovel multipeptide-based diagnostic method. A combination of 7 of these peptides werefinally evaluated in ELISA format against a panel of 199 sera samples (Chagas-positive andnegative, including sera from Leishmaniasis-positive subjects). The multipeptide formulationdisplayed a high diagnostic performance, with a sensitivity of 96.3% and a specificity of99.15%. Therefore, the use of synthetic peptides as diagnostic tools are an attractive alternativein Chagas´ disease diagnosis.
publishDate 2017
dc.date.none.fl_str_mv 2017-10
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/48673
Mucci, Juan Sebastián; Carmona, Santiago Javier; Volcovich, Romina; Altcheh, Jaime Marcelo; Bracamonte, María Estefanía; et al.; Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes; Public Library of Science; Neglected Tropical Diseases; 11; 10; 10-2017; 1-19
1935-2735
CONICET Digital
CONICET
url http://hdl.handle.net/11336/48673
identifier_str_mv Mucci, Juan Sebastián; Carmona, Santiago Javier; Volcovich, Romina; Altcheh, Jaime Marcelo; Bracamonte, María Estefanía; et al.; Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes; Public Library of Science; Neglected Tropical Diseases; 11; 10; 10-2017; 1-19
1935-2735
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://dx.plos.org/10.1371/journal.pntd.0005972
info:eu-repo/semantics/altIdentifier/url/http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0005972
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Public Library of Science
publisher.none.fl_str_mv Public Library of Science
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613736738848768
score 13.070432